EvoAir narrows Q3 loss as revenue more than triples
EVOH•Nine-month results improve
For the nine months ended May 31, net loss narrowed 56% to US$3.12 million as revenue rose 32% to US$211,613.
Operating expenses decline
Operating expenses fell 12% to US$1.09 million, helped by lower general and administrative spending, including reduced professional fees and compliance costs.
Q3 loss narrows as revenue rises sharply
EvoAir reported a net loss of US$1.08 million for the three months ended May 31, 2026, narrowing 9% from a year earlier. Revenue more than doubled to US$123,574, while cost of revenue increased to US$116,751, leaving gross profit of US$6,823.
Management cites growth plans and Nasdaq preparations
Management said it is pursuing distribution expansion, project collaborations, private labeling and licensing, while also seeking additional funding and preparing for a potential .
